These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8251693)

  • 1. Enoxaparin: the low-molecular-weight heparin for prevention of postoperative thromboembolic complications.
    Carter CA; Skoutakis VA; Spiro TE; West ME; Tooms RE; Joe RH; Knutson TJ
    Ann Pharmacother; 1993 Oct; 27(10):1223-30. PubMed ID: 8251693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.
    Noble S; Peters DH; Goa KL
    Drugs; 1995 Mar; 49(3):388-410. PubMed ID: 7774513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danaparoid in the prevention of thromboembolic complications.
    Skoutakis VA
    Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
    Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
    Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery.
    Planes A
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S33-5; discussion S37-8. PubMed ID: 8180327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment: enoxaparin--the low-molecular-weight heparin for prevention of postoperative thromboembolic complications.
    Saltiel E; Saya F
    Ann Pharmacother; 1994 Jun; 28(6):810-1. PubMed ID: 7818656
    [No Abstract]   [Full Text] [Related]  

  • 11. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI; Wille-Jørgensen P; Kälebo P; Mouret P; Rosencher N; Bösch P; Baur M; Ekman S; Bach D; Lindbratt S; Close P
    N Engl J Med; 1997 Nov; 337(19):1329-35. PubMed ID: 9358126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
    Imperiale TF; Speroff T
    JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.
    Deitelzweig SB; Vanscoy GJ; Niccolai CS; Rihn TL
    Ann Pharmacother; 2003 Mar; 37(3):402-11. PubMed ID: 12639173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-Xa activity during administration of low-molecular weight heparin in the prevention of postoperative thromboembolic complications].
    Gürlich R; Salaj P; Hrachovinová I
    Rozhl Chir; 1999 Dec; 78(12):618-21. PubMed ID: 10746083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.
    Iorio A; Agnelli G
    Arch Intern Med; 2000 Aug 14-28; 160(15):2327-32. PubMed ID: 10927730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.